AtriCure Net Income
| ATRC Stock | USD 31.26 0.38 1.20% |
As of the 27th of February, AtriCure shows the Mean Deviation of 2.28, standard deviation of 3.38, and Risk Adjusted Performance of (0.02). AtriCure technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
AtriCure's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing AtriCure's valuation are provided below:AtriCure does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Will Health Care Equipment & Supplies sector continue expanding? Could AtriCure diversify its offerings? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AtriCure data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding AtriCure requires distinguishing between market price and book value, where the latter reflects AtriCure's accounting equity. The concept of intrinsic value - what AtriCure's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push AtriCure's price substantially above or below its fundamental value.
Understanding that AtriCure's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AtriCure represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, AtriCure's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
AtriCure 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AtriCure's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AtriCure.
| 11/29/2025 |
| 02/27/2026 |
If you would invest 0.00 in AtriCure on November 29, 2025 and sell it all today you would earn a total of 0.00 from holding AtriCure or generate 0.0% return on investment in AtriCure over 90 days. AtriCure is related to or competes with Quidel, BioLife Solutions, Kestra Medical, Azenta, 10X Genomics, Novocure, and Xeris Pharmaceuticals. AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and in... More
AtriCure Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AtriCure's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AtriCure upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 24.05 | |||
| Value At Risk | (3.34) | |||
| Potential Upside | 3.39 |
AtriCure Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AtriCure's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AtriCure's standard deviation. In reality, there are many statistical measures that can use AtriCure historical prices to predict the future AtriCure's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.13) |
AtriCure February 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.12) | |||
| Mean Deviation | 2.28 | |||
| Coefficient Of Variation | (2,535) | |||
| Standard Deviation | 3.38 | |||
| Variance | 11.42 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.13) | |||
| Maximum Drawdown | 24.05 | |||
| Value At Risk | (3.34) | |||
| Potential Upside | 3.39 | |||
| Skewness | (0.49) | |||
| Kurtosis | 4.94 |
AtriCure Backtested Returns
AtriCure secures Sharpe Ratio (or Efficiency) of -0.0394, which signifies that the company had a -0.0394 % return per unit of risk over the last 3 months. AtriCure exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AtriCure's Standard Deviation of 3.38, mean deviation of 2.28, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.08, which signifies a somewhat significant risk relative to the market. AtriCure returns are very sensitive to returns on the market. As the market goes up or down, AtriCure is expected to follow. At this point, AtriCure has a negative expected return of -0.13%. Please make sure to confirm AtriCure's potential upside, as well as the relationship between the daily balance of power and price action indicator , to decide if AtriCure performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.05 |
Very weak reverse predictability
AtriCure has very weak reverse predictability. Overlapping area represents the amount of predictability between AtriCure time series from 29th of November 2025 to 13th of January 2026 and 13th of January 2026 to 27th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AtriCure price movement. The serial correlation of -0.05 indicates that only as little as 5.0% of current AtriCure price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.05 | |
| Spearman Rank Test | -0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 8.75 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, AtriCure reported net income of (11.45 Million). This is 103.35% lower than that of the Health Care Equipment & Supplies sector and 111.49% lower than that of the Health Care industry. The net income for all United States stocks is 102.0% higher than that of the company.
AtriCure Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AtriCure's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AtriCure could also be used in its relative valuation, which is a method of valuing AtriCure by comparing valuation metrics of similar companies.AtriCure is currently under evaluation in net income category among its peers.
AtriCure Fundamentals
| Return On Equity | -0.024 | ||||
| Return On Asset | -0.0094 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 1.66 B | ||||
| Shares Outstanding | 49.81 M | ||||
| Shares Owned By Insiders | 3.43 % | ||||
| Shares Owned By Institutions | 96.57 % | ||||
| Number Of Shares Shorted | 2.51 M | ||||
| Price To Earning | 33.47 X | ||||
| Price To Book | 3.67 X | ||||
| Price To Sales | 2.95 X | ||||
| Revenue | 534.53 M | ||||
| Gross Profit | 400.78 M | ||||
| EBITDA | 16.25 M | ||||
| Net Income | (11.45 M) | ||||
| Cash And Equivalents | 118.45 M | ||||
| Cash Per Share | 2.55 X | ||||
| Total Debt | 88.02 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 3.66 X | ||||
| Book Value Per Share | 9.88 X | ||||
| Cash Flow From Operations | 57.33 M | ||||
| Short Ratio | 4.92 X | ||||
| Earnings Per Share | (0.24) X | ||||
| Price To Earnings To Growth | (1.18) X | ||||
| Target Price | 49.38 | ||||
| Number Of Employees | 1.35 K | ||||
| Beta | 1.41 | ||||
| Market Capitalization | 1.58 B | ||||
| Total Asset | 654.18 M | ||||
| Retained Earnings | (413.2 M) | ||||
| Working Capital | 241 M | ||||
| Current Asset | 74.75 M | ||||
| Current Liabilities | 31.59 M | ||||
| Net Asset | 654.18 M |
About AtriCure Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AtriCure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AtriCure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AtriCure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:Check out For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Will Health Care Equipment & Supplies sector continue expanding? Could AtriCure diversify its offerings? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AtriCure data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding AtriCure requires distinguishing between market price and book value, where the latter reflects AtriCure's accounting equity. The concept of intrinsic value - what AtriCure's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push AtriCure's price substantially above or below its fundamental value.
Understanding that AtriCure's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AtriCure represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, AtriCure's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.